Metagenomi, Inc. Common Stock Metagenomi, Inc. Common Stock

Metagenomi, Inc. Common Stock

MGX

Rank in Stocks #25197
Metagenomi, Inc. operates as a biotechnology company focused on gene editing,... Metagenomi, Inc. operates as a biotechnology company focused on gene editing, committed to developing therapeutic solutions for patients. The company utilizes a distinctive genome editing toolkit, sourced from metagenomics, for its development efforts within the United States. This advanced toolkit comprises programmable nucleases, base editors, and sophisticated RNA and DNA-mediated integration systems, notably prime editing and CRISPR-associated transposases. Metagenomi has established several key collaborations: a strategic alliance with ModernaTX, Inc. to explore new genome editing systems for in vivo human therapeutic applications; a development and licensing agreement with Affini-T Therapeutics, Inc. to create and commercialize gene-edited T-cell receptor therapies for human cancer; and a partnership with Ionis Pharmaceuticals, Inc. to research, develop, and market investigational medicines leveraging genome editing technologies. Founded in 2016, the company is based in Emeryville, California.
Share Price
$0.6917
Last synced: 2026-11-13
Market Cap
$26.13M
Change (1 day)
-3.12%
Change (1 year)
-54.19%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade Metagenomi, Inc. Common Stock (MGX)

Category

Healthcare
EPS for Metagenomi, Inc. Common Stock (MGX)
EPS as of September 2026 TTM: $-2.50
According to Metagenomi, Inc. Common Stock's latest financial reports, its current EPS (TTM) is $-2.50. At the end of 2025 the company had an EPS of $-2.36, a decrease compared to its 2024 EPS of $-2.09.
EPS history for Metagenomi, Inc. Common Stock from 2021 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-2.50 5.93%
2025 $-2.36 12.92%
2024 $-2.09 14.84%
2023 $-1.82 56.90%
2022 $-1.16 -67.96%
2021 $-3.62 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$-0.89 -64.40%
US
$15.66 -726.40%
US
$-7.07 182.80%
US
$-5.29 111.60%
AU
$12.73 -609.29%
BE

Questions about Metagenomi, Inc. Common Stock's earnings per share (EPS)

What is Metagenomi, Inc. Common Stock's earnings per share (EPS)?

Metagenomi, Inc. Common Stock's earnings per share (EPS) over the last twelve months is $-2.50, as of Sep 2026.

What was Metagenomi, Inc. Common Stock's earnings per share (EPS) in 2025?

In 2025, Metagenomi, Inc. Common Stock's earnings per share (EPS) was $-2.36, compared with $-2.09 in 2024.

How has Metagenomi, Inc. Common Stock's earnings per share (EPS) changed since 2021?

From 2021 to 2025, Metagenomi, Inc. Common Stock's earnings per share (EPS) was highest in 2022 ($-1.16) and lowest in 2021 ($-3.62).

How does Metagenomi, Inc. Common Stock's earnings per share (EPS) compare with similar companies?

Metagenomi, Inc. Common Stock's earnings per share (EPS) ($-2.50) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.